Stéphane Nahon

Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial

David Laharie, Arnaud Bourreille, Julien Branche et al. · The Lancet · 2012 · 642 citations

Pharmacy, Internal Medicine, Pharmacotherapy +14

Increased Risk for Nonmelanoma Skin Cancers in Patients Who Receive Thiopurines for Inflammatory Bowel Disease

Laurent Peyrin‐Biroulet, Kiarash Khosrotehrani, Fabrice Carrat et al. · Gastroenterology · 2011 · 488 citations · Full text

Medicine, Dermatology, Oncology +16

Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial

Jacques Cosnes, Anne Bourrier, David Laharie et al. · Gastroenterology · 2013 · 266 citations

Medicine, Internal Medicine, Pharmacotherapy +9

Risk factors of anxiety and depression in inflammatory bowel disease

Stéphane Nahon, Pierre Lahmek, Christelle Durance et al. · Inflammatory Bowel Diseases · 2012 · 203 citations · Full text

Social Sciences, Health Sciences, Psychology +13

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab

David Laharie, Arnaud Bourreille, Julien Branche et al. · Gut · 2017 · 155 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +13